Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

Dec 31 (Reuters) - Outlook Therapeutics (OTLK.O), opens new tab said on Wednesday the U.S. health regulator has declined to approve its drug for a type of eye disease, dealing another blow in the ...

New Huawei Android And Windows Tablets Prices In Canada With Technical Specifications Want to know about latest and best huawei tablet price in Canada, grab the best price list of Android and Windows ...

This video explains how ancient Greeks and Romans created curse tablets known as defixiones. Archaeologists have uncovered hundreds of these thin lead sheets across the Mediterranean, often buried in ...

CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a clinical-stage precision oncology company, today announced a definitive asset ...

CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)-- Repare Therapeutics Inc. (RPTX), a clinical-stage precision oncology company, today announced a definitive asset purchase agreement for Gilead Sciences, ...

Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a clinical-stage precision oncology company, today announced a definitive asset purchase agreement for Gilead Sciences, Inc. to ...

Repare Therapeutics Announces Acquisition of Polθ ATPase Inhibitor, RP-3467, by Gilead Sciences for Up To $30 Million in Total Consideration Repare Therapeutics Inc. (“Repare” or the “Company”) ...